PFE beat EPS expectations by 37.46%
Apr 29, 2025, 10:33 PM
0.00%
What does PFE do
Pfizer, a global biopharmaceutical company headquartered in New York City, employs 88,000 people and focuses on discovering, developing, and distributing oncology, primary care, and specialty care products worldwide. Key products include Ibrance, Eliquis, and Xeljanz, among others.
Pfizer (PFE) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Pfizer's actual EPS was $0.92, beating the estimate of $0.67 per share, resulting in a 37.46% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.